Update on Fiasp insulin 17 August 2023 Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. We have been advised that negotiations are continuing. Both the Government and the manufacturer have been made aware of the significant angst this is causing the diabetes community Diabetes Australia will continue to advocate on this issue. We have set up a page – Fight for Fiasp – where you can lend your voice and advocate on this issue. We will keep you updated, as and when we hear anything on this issue.
Media releases 13 May 2026 Momentum builds following government response to diabetes inquiry The diabetes sector has welcomed the Federal Government’s response to the Parliamentary Inquiry into Diabetes, which provides in-principle support for... Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by Diabetes Australia has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading
Blog 22 April 2026 Here’s what happens when lived experience becomes a movement Meet the Blue Circle Collective — a national network of Ambassadors, Advocates, and Advisers united to drive meaningful change for all Australians. What is... Continue Reading
